Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For VRSN
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -2.09 0.81 0.83
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -32.20 3.96 5.84
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -4.49 -16.23 -15.53
Cash 0.81 9.17 9.10
Capex 23.25 -0.04 -0.05
Free Cash Flow 28.52 2.51 1.96
Revenue 2.03 3.81 3.74
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -0.03 0.87 0.87
Operating Margin -0.01 0.67 0.67
ROA -25.77 0.11 0.15
ROE 29.12 -0.12 -0.17
ROIC -1.73 1.24 1.26
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of VRSN is permitted for members.
5 Growth
The "Growth Entry" for the Focus of VRSN is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of VRSN is permitted for members.